Long-acting, injected HIV meds can help tough-to-treat patients
For nearly three decades, daily antiretroviral pills have offered patients living with HIV a highly effective way to keep their infection under control.
Jul 5, 2023
0
16
For nearly three decades, daily antiretroviral pills have offered patients living with HIV a highly effective way to keep their infection under control.
Jul 5, 2023
0
16
The COVID-19 pandemic had substantial psychological impacts on the nation and around the world. New research shows patients with HIV were particularly susceptible to psychosocial challenges like depression, anxiety, substance ...
Jun 29, 2023
0
1
Meningococcal disease—which includes meningitis—appears to be on the rise among Americans infected with HIV, new research reveals.
Jun 29, 2023
0
56
Word choice matters—a lot— when it comes to research. That's the main takeaway from a new article co-authored by Edson College of Nursing and Health Innovation Assistant Professor Angel Algarin and published in Health ...
May 25, 2023
0
19
Implementation of "Treat All," which removed CD4-based clinical staging criteria for antiretroviral therapy (ART) initiation, did not accelerate ART coverage gains or AIDS mortality reductions among pediatric patients with ...
May 19, 2023
0
3
New research from Boston Medical Center found that sexually transmitted infection (STI) and HIV testing declined at the onset of the COVID-19 pandemic, while there was an increase in positive test rates. Published in AIDS ...
Mar 30, 2023
0
2
The Food and Drug Administration has approved Sunlenca, an injectable therapy to suppress HIV for patients who suffered drug resistance to other regimens.
Dec 30, 2022
0
57
The U.S. Food and Drug Administration has approved Sunlenca (lenacapavir), a new type of antiretroviral medication for adult patients living with HIV-1 whose HIV infection cannot be successfully treated with other available ...
Dec 29, 2022
0
14
HIV remains a major public health concern in the United States, with adolescents and young adults (15-24 years old) making up around 20 percent of new infections in the nation each year. Prevention is key to stopping HIV, ...
Dec 12, 2022
0
5
Peter Gulick, a professor in the Michigan State University College of Osteopathic Medicine, has been studying HIV/AIDS since the epidemic began in the early 1980s.
Nov 29, 2022
0
3